Barely Significant
← all excerpts

Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults.

Vaccines (Basel) · 2025 · PMC12298849 · PMID 40733714

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
The antibody increase was highly significant ( p < 0.0001), with a 28-fold GMC increase (95% CI: 17–43-fold) ( Figure 2 B).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.